Trial NCT01293539

View at ClinicalTrials.gov 
Org. Study IDs: J1071
Secondary IDs: NA_00040637

Last trial update was posted on 2018-11-27

MeSH Interventions

Melphalan

MeSH Conditions

Retinoblastoma

Other Conditions


Stopping Reasons

IAC is now recognized as part of standard of care treatment options in the US.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID